Reproductive factors and risk of primary brain tumors in women
详细信息 查看全文
- 作者：Gabriella M. Anic (1)
Melissa H. Madden (1)
L. Burton Nabors (2)
Jeffrey J. Olson (3)
Renato V. LaRocca (4)
Zachary J. Thompson (5)
Shitaldas J. Pamnani (1)
Peter A. Forsyth (6)
Reid C. Thompson (7)
Kathleen M. Egan (1) - 关键词：Glioma ; Meningioma ; Reproductive factors ; Exogenous hormones ; Menarche
- 刊名：Journal of Neuro-Oncology
- 出版年：2014
- 出版时间：June 2014
- 年：2014
- 卷：118
- 期：2
- 页码：297-304
- 全文大小：
- 参考文献：1. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-010. Neuro Oncol 15(Suppl 2):1-6
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97-09 CrossRef
3. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G et al (2007) Long-term survival with glioblastoma multiforme. Brain 130(Pt 10):2596-606 CrossRef
4. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K (2002) Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94(20):1555-563 CrossRef
5. Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319(16):1033-039 CrossRef
6. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41(8):899-04 CrossRef
7. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S et al (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41(8):905-08 CrossRef
8. Dobbins SE, Broderick P, Melin B, Feychting M, Johansen C, Andersson U, Brannstrom T, Schramm J, Olver B, Lloyd A et al (2011) Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet 43(9):825-27 CrossRef
9. Gu J, Liu Y, Kyritsis AP, Bondy ML (2009) Molecular epidemiology of primary brain tumors. Neurotherapeutics 6(3):427-35 CrossRef
10. CBTRUS (2011) Statistical report: primary brain tumors in the United States, 2004-007. Central Brain Tumor Registry of the United States. Available at http://www.cbtrus.org/2011-NPCR-SEER/WEB-0407-Report-3-3-2011.pdf
11. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 20(4):E1 CrossRef
12. McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ (2000) The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg 93(6):932-39 CrossRef
13. De Nicola AF, Brocca ME, Pietranera L, Garcia-Segura LM (2012) Neuroprotection and sex steroid hormones: evidence of estradiol-mediated protection in hypertensive encephalopathy. Mini Rev Med Chem 12(11):1081-089 CrossRef
14. Garcia-Segura LM, Azcoitia I, DonCarlos LL (2001) Neuroprotection by estradiol. Prog Neurobiol 63(1):29-0 CrossRef
15. Kirches E, Warich-Kirches M (2009) 2-methoxyestradiol as a potential cytostatic drug in gliomas? Anticancer Agents Med Chem 9(1):55-5 CrossRef
16. Kang SH, Cho HT, Devi S, Zhang Z, Escuin D, Liang Z, Mao H, Brat DJ, Olson JJ, Simons JW et al (2006) Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model. Cancer Res 66(24):11991-1997 CrossRef
17. Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, Plunkett RJ (2004) 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett 213(1):57-5 CrossRef
18. Chamaon K, Stojek J, Kanakis D, Braeuninger S, Kirches E, Krause G, Mawrin C, Dietzmann K (2005) Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton. J Neurooncol 72(1):11-6 CrossRef
19. Jay JR, MacLaughlin DT, Riley KR, Martuza RL (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62(5):757-62 CrossRef
20. Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou AG, Agnantis NJ (2004) Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol 130(7):405-10 CrossRef
21. Gonzalez-Aguero G, Ondarza R, Gamboa-Dominguez A, Cerbon MA, Camacho-Arroyo I (2001) Progesterone receptor isoforms expression pattern in human astrocytomas. Brain Res Bull 56(1):43-8 CrossRef
22. Khalid H, Shibata S, Kishikawa M, Yasunaga A, Iseki M, Hiura T (1997) Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Cancer 80(11):2133-140 CrossRef
23. Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasalo H (2006) Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 80(1):1- CrossRef
24. Blankenstein MA, Verheijen FM, Jacobs JM, Donker TH, van Duijnhoven MW, Thijssen JH (2000) Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 65(10-1):795-00 CrossRef
25. Khalid H (1994) Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas. Cancer 74(2):679-85 CrossRef
26. Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M (2011) Family and personal medical history and risk of meningioma. J Neurosurg 115(6):1072-077 CrossRef
27. Rao G, Giordano SH, Liu J, McCutcheon IE (2009) The association of breast cancer and meningioma in men and women. Neurosurgery 65(3):483-89 discussion 489
28. Custer BS, Koepsell TD, Mueller BA (2002) The association between breast carcinoma and meningioma in women. Cancer 94(6):1626-635 CrossRef
29. Cowppli-Bony A, Bouvier G, Rue M, Loiseau H, Vital A, Lebailly P, Fabbro-Peray P, Baldi I (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22(5):697-14 CrossRef
30. Little RB, Madden MH, Thompson RC, Olson JJ, Larocca RV, Pan E, Browning JE, Egan KM, Nabors LB (2013) Anthropometric factors in relation to risk of glioma. Cancer Causes Control 24(5):1025-031 CrossRef
31. Qi ZY, Shao C, Zhang X, Hui GZ, Wang Z (2013) Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies. PLoS ONE 8(7):e68695 CrossRef
32. Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE (2011) Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer 128(4):944-50 CrossRef
33. Silvera SA, Miller AB, Rohan TE (2006) Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer 118(5):1321-324 CrossRef
34. Onland-Moret NC, Peeters PH, van Gils CH, Clavel-Chapelon F, Key T, Tjonneland A, Trichopoulou A, Kaaks R, Manjer J, Panico S et al (2005) Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol 162(7):623-32 CrossRef
35. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE (1994) Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78(3):744-52
36. Kitahara CM, Wang SS, Melin BS, Wang Z, Braganza M, Inskip PD, Albanes D, Andersson U, Beane Freeman LE, Buring JE, et al (2012) Association between adult height, genetic susceptibility and risk of glioma. Int J Epidemiol 41(4):1075-085
37. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99(5):848-53 CrossRef
38. Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM (2013) Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg 118(3):649-56 CrossRef
39. Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21(12):2149-156 CrossRef
40. Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, Folsom AR, Virnig BA, Cerhan JR (2011) Risk factors for meningioma in postmenopausal women: results from the Iowa women’s health study. Neuro Oncol 13(9):1011-019 CrossRef
41. Michaud DS, Gallo V, Schlehofer B, Tjonneland A, Olsen A, Overvad K, Dahm CC, Kaaks R, Lukanova A, Boeing H et al (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19(10):2562-569 CrossRef
42. Wigertz A, Lonn S, Hall P, Auvinen A, Christensen HC, Johansen C, Klaeboe L, Salminen T, Schoemaker MJ, Swerdlow AJ et al (2008) Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17(10):2663-670 CrossRef
43. Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G (2006) Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6:152 CrossRef
44. Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F (2006) Association of meningioma with reproductive factors. Int J Cancer 119(5):1152-157 CrossRef
45. Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD (2005) Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114(5):797-05 CrossRef
46. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR et al (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82(2):155-60 CrossRef
47. Felini MJ, Olshan AF, Schroeder JC, Carozza SE, Miike R, Rice T, Wrensch M (2009) Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 20(1):87-6 CrossRef
48. Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J (1992) Medical risk factors and the development of brain tumors. Cancer 69(10):2541-547 CrossRef
49. Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, Giles GG, McNeil JJ (1997) Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 71(2):203-07 CrossRef
50. Huang K, Whelan EA, Ruder AM, Ward EM, Deddens JA, Davis-King KE, Carreon T, Waters MA, Butler MA, Calvert GM et al (2004) Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 13(10):1583-588
51. Benson VS, Pirie K, Green J, Casabonne D, Beral V (2008) Lifestyle factors and primary glioma and meningioma tumours in the million women study cohort. Br J Cancer 99(1):185-90 CrossRef
52. Schlehofer B, Blettner M, Wahrendorf J (1992) Association between brain tumors and menopausal status. J Natl Cancer Inst 84(17):1346-349 CrossRef
53. Lambe M, Coogan P, Baron J (1997) Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 72(3):389-93 CrossRef
54. Wang SS, Hartge P, Yeager M, Carreon T, Ruder AM, Linet M, Inskip PD, Black A, Hsing AW, Alavanja M et al (2011) Joint associations between genetic variants and reproductive factors in glioma risk among women. Am J Epidemiol 174(8):901-08 CrossRef
55. Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164(7):629-36 CrossRef
56. Cea-Soriano L, Blenk T, Wallander MA, Rodriguez LA (2012) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36(2):198-05 CrossRef
57. Michels KB, Manson JE (2003) Postmenopausal hormone therapy: a reversal of fortune. Circulation 107(14):1830-833 CrossRef
58. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS (1992) Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 135(9):1029-041 - 作者单位：Gabriella M. Anic (1)
Melissa H. Madden (1)
L. Burton Nabors (2)
Jeffrey J. Olson (3)
Renato V. LaRocca (4)
Zachary J. Thompson (5)
Shitaldas J. Pamnani (1)
Peter A. Forsyth (6)
Reid C. Thompson (7)
Kathleen M. Egan (1)
1. Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA
2. Neuro-oncology Program, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
3. Department of Neurosurgery, Emory School of Medicine, Atlanta, GA, 30322, USA
4. Norton Cancer Institute, Louisville, KY, 40202, USA
5. Biostatistics and Bioinformatics Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA
6. Department of Neurooncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA
7. Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, 37232, USA - ISSN：1573-7373
文摘
Gender-specific incidence patterns and the presence of hormonal receptors on tumor cells suggest that sex hormones may play a role in the onset of primary brain tumors. However, epidemiological studies on the relation of hormonal risk factors to the risk of brain tumors have been inconsistent. We examined the role of reproductive factors in the onset of glioma and meningioma in a case–control study conducted in the Southeastern US that included 507 glioma cases, 247 meningioma cases, and 695 community-based and friend controls. Unconditional logistic regression was used to estimate odds ratios (ORs) and 95?% confidence intervals (CI) adjusting for age, race, US state of residence, and education. An older age at menarche was associated with an increased risk of glioma (?5 vs. ?2?years: OR 1.65; 95?% CI 1.11-.45), with a stronger association observed in pre-menopausal (OR 2.22; 95?% CI 1.12-.39) than post-menopausal (OR 1.55; 95?% CI 0.93-.58) women. When compared to controls, meningioma cases were more likely to have undergone natural menopause (OR 1.52; 95?% CI 1.04-.21) whereas glioma cases were less likely to be long term users of oral contraceptives (OR 0.47; 95?% CI 0.33-.68). Increasing parity was not related to the risk of either tumor. Current findings are consistent with a limited role for hormones in the onset of brain tumors in women. Results contribute to a growing body of evidence that a later age at menarche increases the risk of glioma?in women.